Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade |
|---|---|
| Source | CAS 1243262-17-0 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Demcizumab,OMP-21M18,DLL4 ,anti-DLL4 |
| Reference | PX-TA1289 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-kappa |
| Clonality | Monoclonal Antibody |
Description of Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade
General information on Anti-DLL4 [Homo sapiens] (Demcizumab) Monoclonal Antibody
Demcizumab is investigated for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.
Related products
Antigen
Human DLL4 recombinant protein
PX-P5121 131$
Isotype Control
Human IgG2 Isotype Control antibody (HyHEL-10)
PTX17900 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.